메뉴 건너뛰기




Volumn 59, Issue , 2016, Pages 13-21

Management of liver metastases in colorectal cancer patients: A retrospective case-control study of systemic therapy versus liver resection

Author keywords

Colorectal liver metastases; Liver resection; Surgical treatment; Survival; Systemic therapy; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROPYRIMIDINE; IRINOTECAN; OXALIPLATIN; PLATINUM COMPLEX;

EID: 84961193248     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2016.02.003     Document Type: Article
Times cited : (52)

References (43)
  • 2
    • 84896855951 scopus 로고    scopus 로고
    • Metastatic pattern in colorectal cancer is strongly influenced by histological subtype
    • N. Hugen, C.J. van de Velde, J.H. de Wilt, and I.D. Nagtegaal Metastatic pattern in colorectal cancer is strongly influenced by histological subtype Ann Oncol 25 3 2014 651 657
    • (2014) Ann Oncol , vol.25 , Issue.3 , pp. 651-657
    • Hugen, N.1    Van De Velde, C.J.2    De Wilt, J.H.3    Nagtegaal, I.D.4
  • 3
    • 84930573159 scopus 로고    scopus 로고
    • Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
    • L.G. van der Geest, J. Lam-Boer, M. Koopman, C. Verhoef, M.A. Elferink, and J.H. de Wilt Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases Clin Exp Metastasis 32 5 2015 457 465
    • (2015) Clin Exp Metastasis , vol.32 , Issue.5 , pp. 457-465
    • Van Der Geest, L.G.1    Lam-Boer, J.2    Koopman, M.3    Verhoef, C.4    Elferink, M.A.5    De Wilt, J.H.6
  • 4
    • 84925517977 scopus 로고    scopus 로고
    • Metachronous metastases from colorectal cancer: A population-based study in North-East Netherlands
    • M.A. Elferink, K.P. de Jong, J.M. Klaase, E.J. Siemerink, and J.H. de Wilt Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands Int J Colorectal Dis 30 2 2015 205 212
    • (2015) Int J Colorectal Dis , vol.30 , Issue.2 , pp. 205-212
    • Elferink, M.A.1    De Jong, K.P.2    Klaase, J.M.3    Siemerink, E.J.4    De Wilt, J.H.5
  • 5
    • 0036104072 scopus 로고    scopus 로고
    • Trends in long-term survival following liver resection for hepatic colorectal metastases
    • M.A. Choti, J.V. Sitzmann, M.F. Tiburi, W. Sumetchotimetha, R. Rangsin, R.D. Schulick, and et al. Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 6 2002 759 766
    • (2002) Ann Surg , vol.235 , Issue.6 , pp. 759-766
    • Choti, M.A.1    Sitzmann, J.V.2    Tiburi, M.F.3    Sumetchotimetha, W.4    Rangsin, R.5    Schulick, R.D.6
  • 6
    • 34547563877 scopus 로고    scopus 로고
    • Hepatic resection for colorectal metastases: Value for risk scoring systems?
    • S. Zakaria, J.H. Donohue, F.G. Que, M.B. Farnell, C.D. Schleck, D.M. Ilstrup, and et al. Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 246 2 2007 183 191
    • (2007) Ann Surg , vol.246 , Issue.2 , pp. 183-191
    • Zakaria, S.1    Donohue, J.H.2    Que, F.G.3    Farnell, M.B.4    Schleck, C.D.5    Ilstrup, D.M.6
  • 7
    • 77952300630 scopus 로고    scopus 로고
    • Survival after hepatic resection for metastatic colorectal cancer: Trends in outcomes for 1,600 patients during two decades at a single institution
    • 752-5
    • M.G. House, H. Ito, M. Gonen, Y. Fong, P.J. Allen, R.P. DeMatteo, and et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution J Am Coll Surg 210 5 2010 744 752 752-5
    • (2010) J Am Coll Surg , vol.210 , Issue.5 , pp. 744-752
    • House, M.G.1    Ito, H.2    Gonen, M.3    Fong, Y.4    Allen, P.J.5    DeMatteo, R.P.6
  • 8
    • 77956856213 scopus 로고    scopus 로고
    • 'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: Differences in clinicopathological features and outcome
    • A.E. van der Pool, Z.S. Lalmahomed, Y. Ozbay, J.H. de Wilt, A.M. Eggermont, J.N. Jzermans, and et al. 'Staged' liver resection in synchronous and metachronous colorectal hepatic metastases: differences in clinicopathological features and outcome Colorectal Dis 12 10 Online 2010 e229 e235
    • (2010) Colorectal Dis , vol.12 , Issue.10 ONLINE , pp. e229-e235
    • Van Der Pool, A.E.1    Lalmahomed, Z.S.2    Ozbay, Y.3    De Wilt, J.H.4    Eggermont, A.M.5    Jzermans, J.N.6
  • 9
    • 77449111760 scopus 로고    scopus 로고
    • Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases
    • D.A. Wicherts, R.J. de Haas, P. Andreani, D. Sotirov, C. Salloum, D. Castaing, and et al. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases Br J Surg 97 2 2010 240 250
    • (2010) Br J Surg , vol.97 , Issue.2 , pp. 240-250
    • Wicherts, D.A.1    De Haas, R.J.2    Andreani, P.3    Sotirov, D.4    Salloum, C.5    Castaing, D.6
  • 10
    • 73249130298 scopus 로고    scopus 로고
    • Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: The CELIM randomised phase 2 trial
    • G. Folprecht, T. Gruenberger, W.O. Bechstein, H.R. Raab, F. Lordick, J.T. Hartmann, and et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial Lancet Oncol 11 1 2010 38 47
    • (2010) Lancet Oncol , vol.11 , Issue.1 , pp. 38-47
    • Folprecht, G.1    Gruenberger, T.2    Bechstein, W.O.3    Raab, H.R.4    Lordick, F.5    Hartmann, J.T.6
  • 11
    • 84869024683 scopus 로고    scopus 로고
    • Survival after liver resection in metastatic colorectal cancer: Review and meta-analysis of prognostic factors
    • G.P. Kanas, A. Taylor, J.N. Primrose, W.J. Langeberg, M.A. Kelsh, F.S. Mowat, and et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors Clin Epidemiol 4 2012 283 301
    • (2012) Clin Epidemiol , vol.4 , pp. 283-301
    • Kanas, G.P.1    Taylor, A.2    Primrose, J.N.3    Langeberg, W.J.4    Kelsh, M.A.5    Mowat, F.S.6
  • 12
    • 84880710191 scopus 로고    scopus 로고
    • Histopathological evaluation of resected colorectal cancer liver metastases: What should be done?
    • N. Knijn, J.A. de Ridder, C.J. Punt, J.H. de Wilt, and I.D. Nagtegaal Histopathological evaluation of resected colorectal cancer liver metastases: what should be done? Histopathology 63 2 2013 149 156
    • (2013) Histopathology , vol.63 , Issue.2 , pp. 149-156
    • Knijn, N.1    De Ridder, J.A.2    Punt, C.J.3    De Wilt, J.H.4    Nagtegaal, I.D.5
  • 13
    • 0029881854 scopus 로고    scopus 로고
    • Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie
    • B. Nordlinger, M. Guiguet, J.C. Vaillant, P. Balladur, K. Boudjema, P. Bachellier, and et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie Cancer 77 7 1996 1254 1262
    • (1996) Cancer , vol.77 , Issue.7 , pp. 1254-1262
    • Nordlinger, B.1    Guiguet, M.2    Vaillant, J.C.3    Balladur, P.4    Boudjema, K.5    Bachellier, P.6
  • 14
    • 33750818936 scopus 로고    scopus 로고
    • Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: Comparison of our scoring system to the positive number of risk factors
    • I. Nagashima, T. Takada, M. Adachi, H. Nagawa, T. Muto, and K. Okinaga Proposal of criteria to select candidates with colorectal liver metastases for hepatic resection: comparison of our scoring system to the positive number of risk factors World J Gastroenterol 12 39 2006 6305 6309
    • (2006) World J Gastroenterol , vol.12 , Issue.39 , pp. 6305-6309
    • Nagashima, I.1    Takada, T.2    Adachi, M.3    Nagawa, H.4    Muto, T.5    Okinaga, K.6
  • 15
    • 57749183889 scopus 로고    scopus 로고
    • Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases
    • R. Konopke, S. Kersting, M. Distler, J. Dietrich, J. Gastmeier, A. Heller, and et al. Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases Liver Int 29 1 2009 89 102
    • (2009) Liver Int , vol.29 , Issue.1 , pp. 89-102
    • Konopke, R.1    Kersting, S.2    Distler, M.3    Dietrich, J.4    Gastmeier, J.5    Heller, A.6
  • 16
    • 0032821469 scopus 로고    scopus 로고
    • Hepatic resection for metastatic colorectal adenocarcinoma: A proposal of a prognostic scoring system
    • S. Iwatsuki, I. Dvorchik, J.R. Madariaga, J.W. Marsh, F. Dodson, A.C. Bonham, and et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system J Am Coll Surg 189 3 1999 291 299
    • (1999) J Am Coll Surg , vol.189 , Issue.3 , pp. 291-299
    • Iwatsuki, S.1    Dvorchik, I.2    Madariaga, J.R.3    Marsh, J.W.4    Dodson, F.5    Bonham, A.C.6
  • 17
    • 77957148013 scopus 로고    scopus 로고
    • Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis
    • M. Hayashi, Y. Inoue, K. Komeda, T. Shimizu, M. Asakuma, F. Hirokawa, and et al. Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis BMC Surg 10 2010 27
    • (2010) BMC Surg , vol.10 , pp. 27
    • Hayashi, M.1    Inoue, Y.2    Komeda, K.3    Shimizu, T.4    Asakuma, M.5    Hirokawa, F.6
  • 18
    • 0033504042 scopus 로고    scopus 로고
    • Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
    • 309-318; discussion 318-21
    • Y. Fong, J. Fortner, R.L. Sun, M.F. Brennan, and L.H. Blumgart Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 3 1999 309-318; discussion 318-21
    • (1999) Ann Surg , vol.230 , Issue.3
    • Fong, Y.1    Fortner, J.2    Sun, R.L.3    Brennan, M.F.4    Blumgart, L.H.5
  • 19
    • 0043244983 scopus 로고    scopus 로고
    • Hepatic resection for colorectal metastases: Can preoperative scoring predict patient outcome?
    • T. Mala, G. Bohler, O. Mathisen, A. Bergan, and O. Soreide Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 26 11 2002 1348 1353
    • (2002) World J Surg , vol.26 , Issue.11 , pp. 1348-1353
    • Mala, T.1    Bohler, G.2    Mathisen, O.3    Bergan, A.4    Soreide, O.5
  • 20
    • 71549167583 scopus 로고    scopus 로고
    • Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases
    • C. Reissfelder, N.N. Rahbari, M. Koch, A. Ulrich, I. Pfeilschifter, A. Waltert, and et al. Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases Ann Surg Oncol 16 12 2009 3279 3288
    • (2009) Ann Surg Oncol , vol.16 , Issue.12 , pp. 3279-3288
    • Reissfelder, C.1    Rahbari, N.N.2    Koch, M.3    Ulrich, A.4    Pfeilschifter, I.5    Waltert, A.6
  • 21
    • 80052775573 scopus 로고    scopus 로고
    • Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy?
    • N. Ayez, Z.S. Lalmahomed, A.E. van der Pool, Y. Vergouwe, K. van Montfort, J. de Jonge, and et al. Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy? Ann Surg Oncol 18 10 2011 2757 2763
    • (2011) Ann Surg Oncol , vol.18 , Issue.10 , pp. 2757-2763
    • Ayez, N.1    Lalmahomed, Z.S.2    Van Der Pool, A.E.3    Vergouwe, Y.4    Van Montfort, K.5    De Jonge, J.6
  • 23
    • 84864677002 scopus 로고    scopus 로고
    • Effect of specialist decision-making on treatment strategies for colorectal liver metastases
    • R.P. Jones, J.N. Vauthey, R. Adam, M. Rees, D. Berry, R. Jackson, and et al. Effect of specialist decision-making on treatment strategies for colorectal liver metastases Br J Surg 99 9 2012 1263 1269
    • (2012) Br J Surg , vol.99 , Issue.9 , pp. 1263-1269
    • Jones, R.P.1    Vauthey, J.N.2    Adam, R.3    Rees, M.4    Berry, D.5    Jackson, R.6
  • 24
    • 84908573757 scopus 로고    scopus 로고
    • FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): A randomised, open-label, phase 3 trial
    • V. Heinemann, L.F. von Weikersthal, T. Decker, A. Kiani, U. Vehling-Kaiser, S.E. Al-Batran, and et al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial Lancet Oncol 15 10 2014 1065 1075
    • (2014) Lancet Oncol , vol.15 , Issue.10 , pp. 1065-1075
    • Heinemann, V.1    Von Weikersthal, L.F.2    Decker, T.3    Kiani, A.4    Vehling-Kaiser, U.5    Al-Batran, S.E.6
  • 25
    • 84908139591 scopus 로고    scopus 로고
    • Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer
    • F. Loupakis, C. Cremolini, G. Masi, S. Lonardi, V. Zagonel, L. Salvatore, and et al. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer N Engl J Med 371 17 2014 1609 1618
    • (2014) N Engl J Med , vol.371 , Issue.17 , pp. 1609-1618
    • Loupakis, F.1    Cremolini, C.2    Masi, G.3    Lonardi, S.4    Zagonel, V.5    Salvatore, L.6
  • 26
    • 68949094312 scopus 로고    scopus 로고
    • Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy
    • S. Kopetz, G.J. Chang, M.J. Overman, C. Eng, D.J. Sargent, D.W. Larson, and et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy J Clin Oncol 27 22 2009 3677 3683
    • (2009) J Clin Oncol , vol.27 , Issue.22 , pp. 3677-3683
    • Kopetz, S.1    Chang, G.J.2    Overman, M.J.3    Eng, C.4    Sargent, D.J.5    Larson, D.W.6
  • 27
    • 79952753550 scopus 로고    scopus 로고
    • High survival rate after two-stage resection of advanced colorectal liver metastases: Response-based selection and complete resection define outcome
    • A. Brouquet, E.K. Abdalla, S. Kopetz, C.R. Garrett, M.J. Overman, C. Eng, and et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome J Clin Oncol 29 8 2011 1083 1090
    • (2011) J Clin Oncol , vol.29 , Issue.8 , pp. 1083-1090
    • Brouquet, A.1    Abdalla, E.K.2    Kopetz, S.3    Garrett, C.R.4    Overman, M.J.5    Eng, C.6
  • 28
    • 34447277453 scopus 로고    scopus 로고
    • Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (Cairo): A phase III randomised controlled trial
    • M. Koopman, N.F. Antonini, J. Douma, J. Wals, A.H. Honkoop, F.L. Erdkamp, and et al. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial Lancet 370 9582 2007 135 142
    • (2007) Lancet , vol.370 , Issue.9582 , pp. 135-142
    • Koopman, M.1    Antonini, N.F.2    Douma, J.3    Wals, J.4    Honkoop, A.H.5    Erdkamp, F.L.6
  • 29
    • 59749091477 scopus 로고    scopus 로고
    • Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer
    • J. Tol, M. Koopman, A. Cats, C.J. Rodenburg, G.J. Creemers, J.G. Schrama, and et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer N Engl J Med 360 6 2009 563 572
    • (2009) N Engl J Med , vol.360 , Issue.6 , pp. 563-572
    • Tol, J.1    Koopman, M.2    Cats, A.3    Rodenburg, C.J.4    Creemers, G.J.5    Schrama, J.G.6
  • 30
    • 77957676744 scopus 로고    scopus 로고
    • A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment
    • N. Snoeren, E.E. Voest, A.M. Bergman, O. Dalesio, H.M. Verheul, R.A. Tollenaar, and et al. A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment BMC Cancer 10 2010 545
    • (2010) BMC Cancer , vol.10 , pp. 545
    • Snoeren, N.1    Voest, E.E.2    Bergman, A.M.3    Dalesio, O.4    Verheul, H.M.5    Tollenaar, R.A.6
  • 31
    • 84930765812 scopus 로고    scopus 로고
    • The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator
    • N. Ayez, E.P. van der Stok, D.J. Grunhagen, J. Rothbarth, E. van Meerten, A.M. Eggermont, and et al. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: clinical risk score as possible discriminator Eur J Surg Oncol 41 7 2015 859 867
    • (2015) Eur J Surg Oncol , vol.41 , Issue.7 , pp. 859-867
    • Ayez, N.1    Van Der Stok, E.P.2    Grunhagen, D.J.3    Rothbarth, J.4    Van Meerten, E.5    Eggermont, A.M.6
  • 32
    • 40749149728 scopus 로고    scopus 로고
    • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial
    • B. Nordlinger, H. Sorbye, B. Glimelius, G.J. Poston, P.M. Schlag, P. Rougier, and et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 9617 2008 1007 1016
    • (2008) Lancet , vol.371 , Issue.9617 , pp. 1007-1016
    • Nordlinger, B.1    Sorbye, H.2    Glimelius, B.3    Poston, G.J.4    Schlag, P.M.5    Rougier, P.6
  • 33
    • 84902006254 scopus 로고    scopus 로고
    • Adjuvant therapy after resection of colorectal liver metastases: The predictive value of the MSKCC clinical risk score in the era of modern chemotherapy
    • N.N. Rahbari, C. Reissfelder, H. Schulze-Bergkamen, D. Jager, M.W. Buchler, J. Weitz, and et al. Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy BMC Cancer 14 2014 174
    • (2014) BMC Cancer , vol.14 , pp. 174
    • Rahbari, N.N.1    Reissfelder, C.2    Schulze-Bergkamen, H.3    Jager, D.4    Buchler, M.W.5    Weitz, J.6
  • 34
    • 84925681839 scopus 로고    scopus 로고
    • Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: The CHARISMA randomized multicenter clinical trial
    • N. Ayez, E.P. van der Stok, H. de Wilt, S.A. Radema, R. van Hillegersberg, R.M. Roumen, and et al. Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial BMC Cancer 15 2015 180
    • (2015) BMC Cancer , vol.15 , pp. 180
    • Ayez, N.1    Van Der Stok, E.P.2    De Wilt, H.3    Radema, S.A.4    Van Hillegersberg, R.5    Roumen, R.M.6
  • 35
    • 84877352669 scopus 로고    scopus 로고
    • Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in the Netherlands
    • L. Mol, M. Koopman, C.W. van Gils, P.B. Ottevanger, and C.J. Punt Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands Acta Oncol 52 5 2013 950 955
    • (2013) Acta Oncol , vol.52 , Issue.5 , pp. 950-955
    • Mol, L.1    Koopman, M.2    Van Gils, C.W.3    Ottevanger, P.B.4    Punt, C.J.5
  • 36
    • 79957477318 scopus 로고    scopus 로고
    • Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection
    • R.J. de Haas, D.A. Wicherts, P. Andreani, G. Pascal, F. Saliba, P. Ichai, and et al. Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection Ann Surg 253 6 2011 1069 1079
    • (2011) Ann Surg , vol.253 , Issue.6 , pp. 1069-1079
    • De Haas, R.J.1    Wicherts, D.A.2    Andreani, P.3    Pascal, G.4    Saliba, F.5    Ichai, P.6
  • 37
    • 84953790659 scopus 로고    scopus 로고
    • Liver resection for metastatic disease; A population-based analysis of trends
    • J.A. de Ridder, V.E. Lemmens, L.I. Overbeek, I.D. Nagtegaal, J.H. de Wilt Dutch Liver Surgery G Liver resection for metastatic disease; a population-based analysis of trends Dig Surg 33 2 2016 104 113
    • (2016) Dig Surg , vol.33 , Issue.2 , pp. 104-113
    • De Ridder, J.A.1    Lemmens, V.E.2    Overbeek, L.I.3    Nagtegaal, I.D.4    De Wilt, J.H.5
  • 38
    • 84864129583 scopus 로고    scopus 로고
    • Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: A randomized EORTC Intergroup phase II study (EORTC 40004)
    • T. Ruers, C. Punt, F. Van Coevorden, J.P. Pierie, I. Borel-Rinkes, J.A. Ledermann, and et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004) Ann Oncol 23 10 2012 2619 2626
    • (2012) Ann Oncol , vol.23 , Issue.10 , pp. 2619-2626
    • Ruers, T.1    Punt, C.2    Van Coevorden, F.3    Pierie, J.P.4    Borel-Rinkes, I.5    Ledermann, J.A.6
  • 39
    • 84938965788 scopus 로고    scopus 로고
    • Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG)
    • J. Huiskens, T.M. van Gulik, K.P. van Lienden, M.R. Engelbrecht, G.A. Meijer, N.C. van Grieken, and et al. Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG) BMC Cancer 15 2015 365
    • (2015) BMC Cancer , vol.15 , pp. 365
    • Huiskens, J.1    Van Gulik, T.M.2    Van Lienden, K.P.3    Engelbrecht, M.R.4    Meijer, G.A.5    Van Grieken, N.C.6
  • 40
    • 36749074593 scopus 로고    scopus 로고
    • Computer-based decision making in medicine: A model for surgery of colorectal liver metastases
    • B.S. Langenhoff, P.F. Krabbe, and T.J. Ruers Computer-based decision making in medicine: a model for surgery of colorectal liver metastases Eur J Surg Oncol 33 Suppl. 2 2007 S111 S117
    • (2007) Eur J Surg Oncol , vol.33 , pp. S111-S117
    • Langenhoff, B.S.1    Krabbe, P.F.2    Ruers, T.J.3
  • 41
    • 84923117454 scopus 로고    scopus 로고
    • Cost-utility analysis of operative versus non-operative treatment for colorectal liver metastases
    • K.J. Roberts, A.J. Sutton, K.R. Prasad, G.J. Toogood, and J.P. Lodge Cost-utility analysis of operative versus non-operative treatment for colorectal liver metastases Br J Surg 102 4 2015 388 398
    • (2015) Br J Surg , vol.102 , Issue.4 , pp. 388-398
    • Roberts, K.J.1    Sutton, A.J.2    Prasad, K.R.3    Toogood, G.J.4    Lodge, J.P.5
  • 42
    • 84900310367 scopus 로고    scopus 로고
    • Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: A randomized clinical trial
    • C.A. Moulton, C.S. Gu, C.H. Law, V.R. Tandan, R. Hart, D. Quan, and et al. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial JAMA 311 18 2014 1863 1869
    • (2014) JAMA , vol.311 , Issue.18 , pp. 1863-1869
    • Moulton, C.A.1    Gu, C.S.2    Law, C.H.3    Tandan, V.R.4    Hart, R.5    Quan, D.6
  • 43
    • 84892723926 scopus 로고    scopus 로고
    • Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: A retrospective analyses stratified by clinical risk score
    • N. Ayez, J. de Ridder, B. Wiering, W.J. Oyen, J.H. de Wilt, and C. Verhoef Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score Dig Surg 30 4-6 2013 451 458
    • (2013) Dig Surg , vol.30 , Issue.4-6 , pp. 451-458
    • Ayez, N.1    De Ridder, J.2    Wiering, B.3    Oyen, W.J.4    De Wilt, J.H.5    Verhoef, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.